TransMedics Group Inc — Cash Flow (NASDAQ:TMDX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 30.27 M28.86 M45.82 M13.03 M48.8 M192.84 M 192.84 M Cash from investing activities 41.6 M29.27 M54.51 M193.95 M129.3 M59.25 M 59.25 M Cash from financing activities 75.55 M1.39 M167.93 M400.42 M22.87 M16.86 M 16.86 M Free cash flow 29.81 M25.34 M33.91 M-138.82 M-80.94 M133.59 M 133.59 M

News

TransMedics clarifies Q4 tax benefit impact on earnings

TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates

Needham raises TransMedics stock price target to $174 on beat

TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call Transcript

TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates

TransMedics surges on earnings beat, solid guidance

Dow Jones Futures: Stock Market Bounces Before Trump Speech, Nvidia Earnings

TransMedics earnings beat by $2.23, revenue topped estimates

Investors brace for TransMedics earnings amid margin questions

Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates

TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial

DexCom (DXCM) Q4 Earnings and Revenues Top Estimates